Kinetic Medical(SZ:300326) Zheng Quan Shi Bao Wang·2025-08-07 07:17Core Viewpoint - ST凯利 is taking significant steps to enhance corporate governance and internal controls following an adverse audit report, indicating a commitment to compliance and risk management [2][3]. Group 1: Corporate Governance and Internal Controls - ST凯利's board has proposed to hold a temporary shareholders' meeting on August 28, 2025, to review key governance and internal control documents [2]. - The company is revising its foundational documents, including the Articles of Association and decision-making rules, to address compliance gaps and clarify responsibilities [2]. - A new anti-fraud and whistleblowing policy has been established to prevent operational risks, emphasizing accountability for violations [2][3]. Group 2: Risk Management and Accountability - To strengthen risk management, ST凯利 plans to purchase liability insurance for all directors and senior management, enhancing their protection while excluding coverage for regulatory penalties due to securities law violations [3]. - The audit committee has been authorized to conduct special audits on departing executives to reinforce accountability mechanisms [3]. Group 3: Management Changes and Business Strategy - ST凯利 intends to appoint 惠一微 as the new deputy general manager, marking a shift in management structure [3]. - The board has approved the sale of a 36.9% stake in 洁诺医疗, indicating a strategic move to divest non-core assets and focus on core areas such as orthopedic medical devices [3]. - The latest financial report shows that ST凯利 achieved a revenue of 265 million yuan in Q1 2025, a year-on-year increase of 7.56%, and a net profit of 21.76 million yuan, up 100.03% year-on-year [3].